Literature DB >> 32479631

Extreme hypofractionation for newly diagnosed glioblastoma: rationale, dose, techniques, and outcomes.

Rupesh Kotecha1,2, Minesh P Mehta1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32479631      PMCID： PMC7594564          DOI： 10.1093/neuonc/noaa133

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  13 in total

1.  Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide.

Authors:  Stuart A Grossman; Xiaobu Ye; Glenn Lesser; Andrew Sloan; Hetty Carraway; Serena Desideri; Steven Piantadosi
Journal:  Clin Cancer Res       Date:  2011-07-07       Impact factor: 12.531

2.  A randomized trial of bevacizumab for newly diagnosed glioblastoma.

Authors:  Mark R Gilbert; James J Dignam; Terri S Armstrong; Jeffrey S Wefel; Deborah T Blumenthal; Michael A Vogelbaum; Howard Colman; Arnab Chakravarti; Stephanie Pugh; Minhee Won; Robert Jeraj; Paul D Brown; Kurt A Jaeckle; David Schiff; Volker W Stieber; David G Brachman; Maria Werner-Wasik; Ivo W Tremont-Lukats; Erik P Sulman; Kenneth D Aldape; Walter J Curran; Minesh P Mehta
Journal:  N Engl J Med       Date:  2014-02-20       Impact factor: 91.245

3.  Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.

Authors:  Antonio Omuro; Kathryn Beal; Philip Gutin; Sasan Karimi; Denise D Correa; Thomas J Kaley; Lisa M DeAngelis; Timothy A Chan; Igor T Gavrilovic; Craig Nolan; Adilia Hormigo; Andrew B Lassman; Ingo Mellinghoff; Christian Grommes; Anne S Reiner; Katherine S Panageas; Raymond E Baser; Viviane Tabar; Elena Pentsova; Juan Sanchez; Renata Barradas-Panchal; Jianan Zhang; Geraldine Faivre; Cameron W Brennan; Lauren E Abrey; Jason T Huse
Journal:  Clin Cancer Res       Date:  2014-08-08       Impact factor: 12.531

4.  Fractionated stereotactic radiation therapy for intracranial tumors.

Authors:  L Souhami; A Olivier; E B Podgorsak; J G Villemure; M Pla; A F Sadikot
Journal:  Cancer       Date:  1991-11-15       Impact factor: 6.860

5.  The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells.

Authors:  Susannah Yovino; Lawrence Kleinberg; Stuart A Grossman; Manisha Narayanan; Eric Ford
Journal:  Cancer Invest       Date:  2013-02       Impact factor: 2.176

6.  Acute and fractionated irradiation differentially modulate glioma stem cell division kinetics.

Authors:  Xuefeng Gao; J Tyson McDonald; Lynn Hlatky; Heiko Enderling
Journal:  Cancer Res       Date:  2012-12-26       Impact factor: 12.701

7.  Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.

Authors:  Alvin R Cabrera; John P Kirkpatrick; John B Fiveash; Helen A Shih; Eugene J Koay; Stephen Lutz; Joshua Petit; Samuel T Chao; Paul D Brown; Michael Vogelbaum; David A Reardon; Arnab Chakravarti; Patrick Y Wen; Eric Chang
Journal:  Pract Radiat Oncol       Date:  2016-03-31

8.  Progress Toward Long-Term Survivors of Glioblastoma.

Authors:  J Nathan Cantrell; Mark R Waddle; Maarten Rotman; Jennifer L Peterson; Henry Ruiz-Garcia; Michael G Heckman; Alfredo Quiñones-Hinojosa; Steven S Rosenfeld; Paul D Brown; Daniel M Trifiletti
Journal:  Mayo Clin Proc       Date:  2019-06-20       Impact factor: 7.616

9.  Impact of volume of irradiation on survival and quality of life in glioblastoma: a prospective, phase 2, randomized comparison of RTOG and MDACC protocols.

Authors:  Narendra Kumar; Ridu Kumar; Suresh C Sharma; Anindya Mukherjee; Niranjan Khandelwal; Manjul Tripathi; Raviteja Miriyala; Arun S Oinam; Renu Madan; Budhi S Yadav; Divya Khosla; Rakesh Kapoor
Journal:  Neurooncol Pract       Date:  2019-07-18

10.  Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma.

Authors:  Michelle M Kim; Hemant A Parmar; Madhava P Aryal; Charles S Mayo; James M Balter; Theodore S Lawrence; Yue Cao
Journal:  Tomography       Date:  2019-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.